Key Considerations When Selecting an mRNA CDMO Partner

This webinar will highlight the challenges in in the field of mRNA-based therapeutics, a strategy to design mRNA-LNP process for at-scale manufacturing, and the importance of end-to-end service.

Register Free: https://globalmeet.webcasts.com/starthere.jsp?ei=1584222&tp_key=4b27ce8751

Event Overview:

CDMO competition can be expected to intensify since mRNA manufacturing capacity and CDMOs’ capabilities both expanded significantly to meet the need associated with the pandemic. From a technical standpoint, the processes associated with mRNA manufacture generally are still new; this is pioneering work. This webinar will highlight the challenges in in the field of mRNA-based therapeutics, a strategy to design mRNA-LNP process for at-scale manufacturing, and the importance of end-to-end service. Lastly, the in-house capability of Samsung Biologics as mRNA CDMO company will be introduced.

Key Learning Objectives:

• Criteria to consider when choosing a mRNA CDMO partner
• How to develop mRNA-LNP process
• Importance of the end-to-end CDMO service
• Samsung Biologics mRNA services’ Strength

Speakers:

Pierre Catignol
Executive Vice President, Head of Manufacturing
Samsung Biologics

Pierre Catignol is the Executive Vice President and Head of Manufacturing at Samsung Biologics. He is a recognized industry expert with a demonstrated history of 26+ years in the biopharmaceutical and pharmaceutical industry. Prior to joining Samsung Biologics, Pierre held a leadership role at Lonza serving as the Head of the Portsmouth, NH (USA) and Porriño, Spain sites. He also served as Site Head at Virbac & Sanofi Pasteur, as well as Senior Vice President of Technical Operations & Supply Chain at Stallergenes Greer earlier in his career. Pierre holds a master's degree in general engineering from ECAM LaSalle.

Eunseo (Ency) Lee
Senior Scientist
Samsung Biologics

Eunseo (Ency) Lee, Ph.D is the Senior Scientist of mRNA T/F at Samsung Biologics. After joining Samsung Biologics in 2021, she has led the tech transfer project in both lab- and at-scale lipid nanoparticle manufacturing process. She holds a Master/Ph.D degree in Chemical and Biological Engineering from Seoul National University, South Korea, and a bachelor’s degree in Chemical Engineering from University of Notre Dame, USA.

Register Free: https://globalmeet.webcasts.com/starthere.jsp?ei=1584222&tp_key=4b27ce8751